| Execution period | 12 months |
|---|
BSE filing, NSE: MOLBIO. Summary written from the filing by ALFA Finder's alert engine.
Molbio Diagnostics Ltd: key numbers
- Share price
- ₹1,312.70
- Market cap
- ₹15,128 Cr
- Revenue (annual)
- ₹1,446 Cr
- Net profit (annual)
- ₹166.6 Cr
- Promoter holding
- 41.29%
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Molbio Diagnostics Ltd
All →Molbio Diagnostics Price Movement Clarification
Molbio Diagnostics responded to NSE's spurt-in-volume query, stating the movement is purely market-driven. No pending price-sensitive information is slated for disclosure.
Molbio Diagnostics Other Announcement
Molbio Diagnostics Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure provides information on promoter and public shareholding structures.
Molbio Diagnostics Capital Structure Change
Kotak Mahindra Mutual Fund acquired 5,70,000 Molbio Diagnostics shares in the open market on 08 October 2026. Its stake crossed 5% to 5.4834%.
Molbio Diagnostics Board Meeting Outcome
Molbio Diagnostics Limited has re-appointed M/s K. S. Kamalakara & Co as its Cost Auditor for the financial year 2026-27. The Board approved the appointment today.
- Execution
- Financial Year 2026-27
Molbio Diagnostics Capital Structure Change
India Business Excellence Fund III sold 30,00,000 shares (2.60% stake) of Molbio Diagnostics Limited. The transaction was executed via open market on September 23, 2026.
Molbio Diagnostics Earnings Call Transcript: Key Takeaways
Molbio reported Q1 FY27 revenue of ₹408 Cr with a 25% EBITDA margin. Strategy focuses on expanding Truenat's global footprint and integrating digital pathology via OptraScan.
- Call
- Guides 25% growth
Other other announcement announcements
All →Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.
Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.
Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.
Barflex Polyfilms Other Announcement
Barflex Polyfilms filed that LODR corporate governance provisions are not applicable as an NSE SME-listed company for the quarter ended 30-09-2026. The accompanying quarterly investor-complaints statement (Reg 13(3)) recorded zero complaints.
Avantel Other Announcement
Avantel dispatched Reg 36(1)(b) letters to shareholders without registered emails, providing a web link to the Postal Ballot notice. The letter facilitates email registration for remote e-voting.